CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Large Growth in Short Interest

by · The Markets Daily

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Free Report) was the target of a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 1,444,389 shares, an increase of 144,438,800.0% from the July 15th total of 1 shares. Based on an average daily trading volume, of 10,945,936 shares, the days-to-cover ratio is currently 0.1 days.

CNBX Pharmaceuticals Price Performance

Shares of OTCMKTS CNBX traded up $0.00 during midday trading on Tuesday, hitting $0.00. 4,137,084 shares of the stock traded hands, compared to its average volume of 30,466,232. CNBX Pharmaceuticals has a one year low of $0.00 and a one year high of $0.00.

About CNBX Pharmaceuticals

(Get Free Report)

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.

Featured Stories